Expanded Access Policy

Climb Bio’s investigational therapies are still being studied in clinical trials to evaluate their safety and effectiveness and are not approved by the FDA or other regulatory agencies.

Climb Bio does not currently provide access to our investigational therapies outside of enrollment in clinical trials.

Clinical trials are the most appropriate and most common way to access investigational therapies before they are approved by the Food and Drug Administration (FDA) or other regulatory agencies.

To learn more about Climb Bio’s ongoing clinical trials, please visit clinicaltrials.gov.  For additional information about Climb Bio’s Expanded Access Policy, please contact [email protected].

Climb Bio reserves the right to revise this Expanded Access Policy at any time in accordance with the 21^st Century Cures Act.